Page 14 - Aml Kyc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aml kyc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aml Kyc Today - Breaking & Trending Today

Intensity of Consolidation Pre-Transplant Shows No Difference in Outcomes in Older AML

No difference in relapse-free survival or non–relapse mortality was seen with intensive vs non-intensive consolidation chemotherapy regimens prior to allogeneic hematopoietic stem cell transplantation in elderly patients over the age of 60 with acute myeloid leukemia in first complete remission.

....

Yosr Hicheri , Institut Paoli Clamettes , Department Of Clinical Hematology , Clinical Hematology , European Leukemianet , Society Of Hematologic Oncology Annual Meeting Soho , Hematologic Oncology , Consolidation Pre Transplant , Acute Myeloid Leukemia ,

Acute Lymphoblastic Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

Shared insight from key opinion leaders on clinical trial data in acute lymphoblastic leukemia from the ASCO 2023 and EHA 2023 Annual Meetings. ....

Lymphoblastic Leukemia , Trial Data From , Asco 2023 , Eha 2023 , American Society Of Clinical Oncology , European Hematology Association , Asco 2023 Annual Meeting , Eha 2023 Congress , Acute Lymphoblastic Leukemia , Chronic Myeloid Leukemia , Acute Myeloid Leukemia ,

Acute Myeloid Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

Following the ASCO 2023 and EHA 2023 Annual Meetings, experts discuss important updates in acute myeloid leukemia. ....

Myeloid Leukemia , Trial Data From , Asco 2023 , Eha 2023 , American Society Of Clinical Oncology , European Hematology Association , Asco 2023 Annual Meeting , Eha 2023 Congress , Acute Lymphoblastic Leukemia , Chronic Myeloid Leukemia , Acute Myeloid Leukemia ,

Older Patients With AML Less Likely to Receive Genomic Testing, Study Finds

A study highlights an unmet need for patients with acute myeloid leukemia (AML) to access and afford genomic testing, especially among an older patient population. ....

United States , National Cancer Institute , Indiana University Health System Enterprise Data Warehouse , Cancer Medicine , Acute Myeloid Leukemia , Genomic Testing ,

REGAL Trial Examining Galinpepimut-S in AML to Continue Without Modifications

An independent data monitoring committee has recommended that the phase 3 REGAL trial evaluating galinpepimut-S in patients with acute myeloid leukemia should continue without modifications. ....

Angelos Stergiou , Life Sciences Group Inc , Life Sciences , Life Sciences Independent Monitoring Committee , Sciences Group , Sciences Independent Monitoring Committee , Hematologic Oncology , Hase 3 Regal Trial , Acute Myeloid Leukemia ,